For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
‘Tired but not demoralised’ GP in Sydney outbreak reflects
Wednesday 2 February 2022, 03:05 AM

COVID-19 passes the baton to another variant [Cemile Bingol on iStock]
Martin Johnston describes life during an Omicron surge in New South Wales, as told by a GP academic
Key points, Specialist GP Dimity Pond says systems for previous COVID-19 waves do not work for managing patients in an Omicron outbreak.
Professor Pond’s north
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.